Participants 0 88 5
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients:
Participants 143 247 5
Breast cancer patients with treatment-induced menopause experience frequent and severe hot flashes (HF).
Participants 434 580 5
60 breast cancer patients experiencing HF were randomized to 8 weeks venlafaxine followed by 2 weeks wash-out, and 8 weeks clonidine or vice versa
Participants 676 738 3
Thirty patients started with venlafaxine and 30 with clonidine
